Research News

  • Navigating the Nexus: Littenberg and van Eeghen Advocate IBH Interventions
    A recent study by Benjamin Littenberg, M.D., and Constance van Eeghen, Dr.P.H., in collaboration with colleagues across the U.S., explores integrative behavioral health (IBH) interventions to address the intertwined challenges of mental and physical health. IBH interventions do show benefits; however, systemic challenges in the health care landscape hinder widespread adoption, underscoring the need for a unified and effective patient care approach.
  • Autoimmune Disease Linked to Increased Survival Rates in Blood Disorders Patients
    Autoimmune disease is frequent in patients with myelodysplastic syndromes, but studies have been inconclusive about how the preexistence of autoimmunity affects survival in these patients. A new study by UVM Cancer Center member Diego Adrianzen Herrera, M.D. uses an epidemiologic analysis to clarify that issue.
  • Tighe, Dragon, Tracy Featured in WCAX Story on Space Launch of UVM DNA Extraction Technology
    (NOVEMBER 16, 2023) Scott Tighe, technical director for the Advanced Genome Technologies Core, along with Julie Dragon, Ph.D., and Kirsten Tracy, Ph.D., were featured on WCAX-TV in a story about their µTitan project, which was launched into space on November 9.
    Read full story at WCAX-TV
  • Reconsidering Resilience: Insights from Copeland’s Research
    Most children are exposed to adversity by the time they reach adulthood, but a portion of children stay free of mental illness despite trying circumstances. A recent study led by Professor of Psychiatry William Copeland, Ph.D., and supported by UVM researchers, challenges the notion that childhood resilience is common and explores possible solutions to this crisis via public health initiatives.
  • Tighe’s DNA Extraction Work Reaches New Heights
    (NOVEMBER 10, 2023) A lyophilized whole-cell mix of 10 bacterial species customized by Scott Tighe, technical director at the University of Vermont’s advanced genomics lab, and colleagues, was sent to the International Space Station aboard the SpaceX CRS-29 Cargo Dragon Resupply Craft mission on November 9.
    Read full story at Pharmaceutical Daily
  • Lyme Disease Prevention Vaccine Clinical Trial Launches in Vermont
    There are currently no approved vaccines available to prevent Lyme disease in humans, but one may be on the way. UVM’s Vaccine Testing Center recently launched a clinical study to investigate the efficacy, safety, and immunogenicity of a Lyme disease vaccine.
  • Stevenson Named Distinguished Graduate Alumnus
    Andra Stevenson, Ph.D.’01, Returns to UVM to Share Insights on Mentorship and Career Journey
  • New study in Science Advances reveals insights into the regulation of glutathione
    Research by Yvonne Janssen-Heininger, Ph.D., and Reem Aboushousha, Ph.D, uncovered a novel facet of glutaredoxin, a prominent player in humans’ antioxidant defense system . The findings bear substantial implications in the field of cancer biology.
  • Summer Scholars: Medical Students Dive Into Research
    Each summer, many rising second-year medical students engage in clinical, basic science or health policy-related research projects under the guidance of expert faculty. The students choose their topics based on personal passions and immerse themselves in projects tackling medical puzzles and unmet health needs. Engaging in research can be among the most valuable experiences during a medical education.
  • The Dean's Celebration of Excellence in Research
    The University of Vermont and UVM Larner College of Medicine are delighted to announce the upcoming "Dean's Celebration of Excellence in Research," a weeklong celebration dedicated to showcasing the exceptional research endeavors of faculty, research fellows, and graduate students. Held September 18 to 22, 2023, this year’s series promises to be an extraordinary platform for academic discovery and collaboration.